NCT04441450View on ClinicalTrials.gov

ADME Study of [14C]ICP-022 in Healthy Males

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

August 6, 2019

Study Completion Date

August 6, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

[14C]ICP-022

150mg suspension containing 100μCi of \[14C\]ICP-022

Trial Locations (1)

Unknown

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

Beijing InnoCare Pharma Tech Co., Ltd.

INDUSTRY

NCT04441450 - ADME Study of [14C]ICP-022 in Healthy Males | Biotech Hunter | Biotech Hunter